These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 4790614)

  • 1. Enhanced toxicity for mice of combinations of bacterial endotoxin with antitumor drugs.
    Marecki NM; Bradley SG
    Antimicrob Agents Chemother; 1973 May; 3(5):599-606. PubMed ID: 4790614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced toxicity for mice of vincristine and other chemotherapeutic agents with Salmonella typhosa endotoxin and Pseudomonas aeruginosa.
    Rose WC; Bradley SG; Lee IP
    Antimicrob Agents Chemother; 1972 Jun; 1(6):489-95. PubMed ID: 4218944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced toxicity for mice of combinations of antibiotics with Escherichia coli cells or Salmonella typhosa endotoxin.
    Rose WC; Bradley SG
    Infect Immun; 1971 Nov; 4(5):550-5. PubMed ID: 4949506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced toxicity for mice of 6-mercaptopurine with bacterial endotoxin.
    Marecki NM; Bradley SG
    Antimicrob Agents Chemother; 1974 Apr; 5(4):413-9. PubMed ID: 15825398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potentiation of the toxicity of several antitumor agents by Salmonella typhosa endotoxin.
    Rose WC; Bradley SG; Lee IP
    Toxicol Appl Pharmacol; 1972 Sep; 23(1):102-11. PubMed ID: 5071034
    [No Abstract]   [Full Text] [Related]  

  • 6. Enhanced toxicity for mice of pactamycin with bacterial endotoxin.
    Bradley SG; Rose WC
    Antimicrob Agents Chemother; 1973 Jun; 3(6):686-92. PubMed ID: 4790618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced cytotoxicity in mice of combinations of concanavalin A and selected antitumor drugs.
    Bradley SG; Marecki NM; Bond JS; Munson AE; John DT
    Adv Exp Med Biol; 1975; 55():291-307. PubMed ID: 168746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of phenobarbital and endotoxin on the lethality and metabolism of 6-mercaptopurine in male BALB/c mice.
    Higuchi T; Nakamura T; Uchino H
    Cancer Res; 1977 Oct; 37(10):3668-71. PubMed ID: 908014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Basis of observed resistance of L1210 leukemia in mice: methotrexate, 6-thioguanine, 6-methylmercaptopurine riboside, 6-mercaptopurine, 5-fluorouracil, and 1-beta-D-arabinofuranosylcytosine administered in different combinations.
    Kim K; Blechman WJ; Riddle VG; Pardee AB
    Cancer Res; 1981 Nov; 41(11 Pt 1):4529-34. PubMed ID: 7198006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toxic interactions of benzyl alcohol with bacterial endotoxin.
    Cebula TA; El-Hage AN; Ferrans VJ
    Infect Immun; 1984 Apr; 44(1):91-6. PubMed ID: 6368395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced post-irradiation recovery of the haemopoietic system in animals pretreated with a variety of cytotoxic agents.
    Millar JL; Blackett NM; Hudspith BN
    Cell Tissue Kinet; 1978 Sep; 11(5):543-53. PubMed ID: 719696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of endotoxin on the pharmacology of antineoplastic agents.
    Lu K; Rosenblum MG; Loo TL
    Cancer Chemother Pharmacol; 1981; 5(4):227-31. PubMed ID: 7261251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potentiation of the toxicity of mithramycin by bacterial lipopolysaccharide.
    Bradley SG; Adams AC; Smith MC
    Antimicrob Agents Chemother; 1975 Mar; 7(3):322-7. PubMed ID: 124549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variation in toxicity of Escherichia coli endotoxin after treatment with perfluorated blood substitutes in mice.
    Lutz J; Barthel U; Metzenauer P
    Circ Shock; 1982; 9(2):99-106. PubMed ID: 7044601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MODIFICATION OF HOST RESPONSES TO BACTERIAL ENDOTOXINS. I. SPECIFICITY OF PYROGENIC TOLERANCE AND THE ROLE OF HYPERSENSITIVITY IN PYROGENICITY, LETHALITY, AND SKIN REACTIVITY.
    WATSON DW; KIM YB
    J Exp Med; 1963 Sep; 118(3):425-46. PubMed ID: 14078002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DRUGS OF CURRENT USE FOR THE TREATMENT OF CANCER AND ALLIED DISEASES.
    GOLDENBERG DM
    Dis Chest; 1963 Dec; 51():191-208. PubMed ID: 14102116
    [No Abstract]   [Full Text] [Related]  

  • 17. Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin.
    Beutler B; Milsark IW; Cerami AC
    Science; 1985 Aug; 229(4716):869-71. PubMed ID: 3895437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of solcoseryl on antitumour action and acute toxicity of some antineoplastic drugs.
    Danysz A; Sołtysiak-Pawluczuk D; Czyzewska-Szafran H; Jedrych A; Jastrzebski Z
    Drugs Exp Clin Res; 1991; 17(2):133-8. PubMed ID: 1864228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of enhanced toxicity of 6-mercaptopurine with endotoxin.
    Higuchi T; Nakamura T; Uchino H
    Biochem Pharmacol; 1978; 27(21):2507-11. PubMed ID: 728205
    [No Abstract]   [Full Text] [Related]  

  • 20. Failure of bacterial endotoxin to produce the generalized Shwartzman reaction in the Syrian hamster.
    Merritt K; Galton M
    J Bacteriol; 1967 Sep; 94(3):590-6. PubMed ID: 5340677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.